• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与晚期癌症患者多中心纵向观察研究中患者流失相关的因素。

Factors Associated With Attrition in a Multicenter Longitudinal Observational Study of Patients With Advanced Cancer.

机构信息

Department of Internal Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Department of Palliative Care, King Hussein Cancer Center, Amman, Jordan.

出版信息

J Pain Symptom Manage. 2018 Mar;55(3):938-945. doi: 10.1016/j.jpainsymman.2017.11.009. Epub 2017 Nov 16.

DOI:10.1016/j.jpainsymman.2017.11.009
PMID:29155290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5834396/
Abstract

CONTEXT

Attrition is common in longitudinal observational studies in palliative care. Few studies have examined predictors of attrition.

OBJECTIVES

To identify patient characteristics at enrollment associated with attrition in palliative oncology outpatient setting.

METHODS

In this longitudinal observational study, advanced cancer patients enrolled in an outpatient multicenter study were assessed at baseline and two to five weeks later. We compared baseline characteristics between patients who returned for follow-up and those who dropped out.

RESULTS

Seven hundred forty-four patients were enrolled from Jordan, Brazil, Chile, Korea, and India. Attrition rate was 33%, with variation among countries (22%-39%; P = 0.023). In univariate analysis, baseline predictors for attrition were cognitive failure (odds ratio [OR] 1.23 per point in Memorial Delirium Assessment Scale; P < 0.01), functional status (OR 1.55 per 10-point decrease in Karnofsky Performance Status; P < 0.01), Edmonton Symptom Assessment Scale [ESAS] physical score (OR 1.03 per point; P < 0.01), ESAS emotional score (OR 1.05 per point; P < 0.01), and shorter duration between cancer diagnosis and palliative care referral in months (OR 0.89 per log; P = 0.028). In multivariate analysis, cognitive failure (OR 1.12 per point; P = 0.007), ESAS physical score (OR 1.18 per point; P = 0.027), functional status (OR 1.35 per 10-point decrease; P < 0.001), and shorter duration from cancer diagnosis (OR 0.86 per log; P = 0.01) remained independent predictors of attrition.

CONCLUSION

Advanced cancer patients with cognitive failure, increased physical symptoms, poorer performance status, and shorter duration from cancer diagnosis were more likely to dropout. These results have implications for research design, patient selection, and data interpretation in longitudinal observational studies.

摘要

背景

在姑息治疗的纵向观察性研究中,失访很常见。很少有研究探讨失访的预测因素。

目的

确定姑息肿瘤门诊环境中与失访相关的入组时患者特征。

方法

在这项纵向观察性研究中,招募了来自约旦、巴西、智利、韩国和印度的晚期癌症患者,在基线和 2 至 5 周后进行评估。我们比较了返回随访和失访患者的基线特征。

结果

从约旦、巴西、智利、韩国和印度招募了 744 名患者。失访率为 33%,各国之间存在差异(22%-39%;P=0.023)。在单因素分析中,失访的基线预测因素包括认知失败(在 Memorial 谵妄评估量表中每增加 1 分,比值比 [OR] 为 1.23;P<0.01)、功能状态(Karnofsky 表现状态每降低 10 分,OR 为 1.55;P<0.01)、埃德蒙顿症状评估量表[ESAS]身体评分(每增加 1 分,OR 为 1.03;P<0.01)、ESAS 情绪评分(每增加 1 分,OR 为 1.05;P<0.01)和癌症诊断与姑息治疗转介之间的时间(以月为单位,OR 为 0.89/对数;P=0.028)。多因素分析中,认知失败(OR 为 1.12/分;P=0.007)、ESAS 身体评分(OR 为 1.18/分;P=0.027)、功能状态(OR 为每降低 10 分,1.35;P<0.001)和癌症诊断时间(OR 为 0.86/对数;P=0.01)仍然是失访的独立预测因素。

结论

认知失败、身体症状增加、功能状态较差和癌症诊断后时间较短的晚期癌症患者更有可能失访。这些结果对纵向观察性研究的研究设计、患者选择和数据解释具有启示意义。

相似文献

1
Factors Associated With Attrition in a Multicenter Longitudinal Observational Study of Patients With Advanced Cancer.与晚期癌症患者多中心纵向观察研究中患者流失相关的因素。
J Pain Symptom Manage. 2018 Mar;55(3):938-945. doi: 10.1016/j.jpainsymman.2017.11.009. Epub 2017 Nov 16.
2
Impact of outpatient palliative care (PC) on symptom burden in patients with advanced cancer at a tertiary cancer center in Jordan.约旦一家三级癌症中心门诊姑息治疗对晚期癌症患者症状负担的影响。
Support Care Cancer. 2017 Jan;25(1):177-183. doi: 10.1007/s00520-016-3395-8. Epub 2016 Sep 7.
3
Attrition rates, reasons, and predictive factors in supportive care and palliative oncology clinical trials.支持性护理和肿瘤姑息治疗临床试验中的脱落率、原因和预测因素。
Cancer. 2013 Mar 1;119(5):1098-105. doi: 10.1002/cncr.27854. Epub 2012 Nov 6.
4
Symptom Expression in Patients with Advanced Cancer Admitted to an Acute Supportive/Palliative Care Unit With and Without Delirium.伴有和不伴有谵妄的晚期癌症患者入住急性支持/姑息治疗病房的症状表现。
Oncologist. 2019 Jun;24(6):e358-e364. doi: 10.1634/theoncologist.2018-0244. Epub 2018 Oct 24.
5
Feasibility of Conducting a Palliative Care Randomized Controlled Trial in Children With Advanced Cancer: Assessment of the PediQUEST Study.在晚期癌症儿童中开展姑息治疗随机对照试验的可行性:PediQUEST研究评估
J Pain Symptom Manage. 2015 Jun;49(6):1059-69. doi: 10.1016/j.jpainsymman.2014.12.010. Epub 2015 Jan 30.
6
A longitudinal study of palliative care: patient-evaluated outcome and impact of attrition.姑息治疗的纵向研究:患者评估结果及失访影响
Cancer. 2005 Apr 15;103(8):1747-55. doi: 10.1002/cncr.20958.
7
Integrating Palliative Care Services in Ambulatory Oncology: An Application of the Edmonton Symptom Assessment System.在门诊肿瘤学中整合姑息治疗服务:埃德蒙顿症状评估系统的应用
J Oncol Pract. 2017 Apr;13(4):e401-e407. doi: 10.1200/JOP.2016.019372. Epub 2017 Mar 16.
8
Delirium assessed by Memorial Delirium Assessment Scale in advanced cancer patients admitted to an acute palliative/supportive care unit.采用纪念谵妄评估量表对入住急性姑息/支持治疗病房的晚期癌症患者的谵妄情况进行评估。
Curr Med Res Opin. 2017 Jul;33(7):1303-1308. doi: 10.1080/03007995.2017.1315332. Epub 2017 May 5.
9
Factors associated with attrition from a randomized controlled trial of meaning-centered group psychotherapy for patients with advanced cancer.与参加一项针对晚期癌症患者的以意义为中心的团体心理治疗的随机对照试验中患者脱落相关的因素。
Psychooncology. 2012 Nov;21(11):1195-204. doi: 10.1002/pon.2013. Epub 2011 Jul 12.
10
Clinical response to an outpatient palliative care consultation in patients with advanced cancer and cancer pain.晚期癌症和癌痛患者门诊姑息治疗咨询的临床反应。
J Pain Symptom Manage. 2012 Sep;44(3):340-50. doi: 10.1016/j.jpainsymman.2011.09.014. Epub 2012 Jun 13.

引用本文的文献

1
Feasibility, Acceptability, and Potential Effects of a Digital Oral Anticancer Agent Intervention: Protocol for a Pilot Randomized Controlled Trial.数字口服抗癌药物干预的可行性、可接受性及潜在效果:一项试点随机对照试验方案
JMIR Res Protoc. 2025 Mar 26;14:e55475. doi: 10.2196/55475.
2
Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real world.现实世界中转移性乳腺癌患者一线至二线治疗失败的相关因素。
ESMO Open. 2025 Feb;10(2):104125. doi: 10.1016/j.esmoop.2024.104125. Epub 2025 Jan 21.
3
The effect of social care nurses on health related quality of life in patients with advanced cancer: A non-randomized, multicenter, controlled trial.社会护理护士对晚期癌症患者健康相关生活质量的影响:一项非随机、多中心对照试验。
Qual Life Res. 2024 Dec;33(12):3387-3399. doi: 10.1007/s11136-024-03780-3. Epub 2024 Sep 13.
4
Symptom burden among men treated for castration-resistant prostate cancer: a longitudinal study.去势抵抗性前列腺癌男性患者的症状负担:一项纵向研究。
BMJ Support Palliat Care. 2024 Dec 25;15(1):87-95. doi: 10.1136/spcare-2024-005054.
5
An exploratory study of a multi-species probiotic formulation and markers of health in a real-world oncological cohort in the time of covid.一项关于多菌种益生菌配方和新冠疫情期间真实肿瘤队列健康标志物的探索性研究。
Inflammopharmacology. 2024 Aug;32(4):2317-2335. doi: 10.1007/s10787-024-01503-1. Epub 2024 Jun 26.
6
Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry.德国真实世界PRAEGNANT注册研究中晚期乳腺癌患者前三线治疗的损耗情况
Geburtshilfe Frauenheilkd. 2024 May 29;84(5):459-469. doi: 10.1055/a-2286-5372. eCollection 2024 May.
7
A Multimodal Lifestyle Psychosocial Survivorship Program in Young Cancer Survivors: The CARE for CAYA Program-A Randomized Clinical Trial Embedded in a Longitudinal Cohort Study.多模态生活方式心理社会康复计划在年轻癌症幸存者中的应用:CARE for CAYA 项目——一项纵向队列研究中嵌入的随机临床试验。
JAMA Netw Open. 2024 Mar 4;7(3):e242375. doi: 10.1001/jamanetworkopen.2024.2375.
8
Head and neck cancer patients with geriatric deficits are more often non-responders and lost from follow-up in quality of life studies.头颈部癌症合并老年综合征的患者在生活质量研究中更常出现无应答和失访。
Eur Arch Otorhinolaryngol. 2024 May;281(5):2619-2626. doi: 10.1007/s00405-024-08528-w. Epub 2024 Mar 1.
9
Feasibility and effectiveness of a two-tiered intervention involving training and a new consultation model for patients with palliative care needs in primary care: A before-after study.在初级保健中为有姑息治疗需求的患者提供培训和新咨询模式的双层干预措施的可行性和有效性:一项前后研究。
Palliat Med. 2024 Sep;38(8):842-852. doi: 10.1177/02692163231219682. Epub 2024 Jan 16.
10
Feasibility of a Health Coach Intervention to Reduce Sitting Time and Improve Physical Functioning Among Breast Cancer Survivors: Pilot Intervention Study.健康教练干预对减少乳腺癌幸存者久坐时间并改善身体机能的可行性:试点干预研究
JMIR Cancer. 2023 Dec 19;9:e49934. doi: 10.2196/49934.

本文引用的文献

1
Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial.劳拉西泮联合氟哌啶醇与单用氟哌啶醇对接受姑息治疗的晚期癌症患者激越性谵妄的影响:一项随机临床试验。
JAMA. 2017 Sep 19;318(11):1047-1056. doi: 10.1001/jama.2017.11468.
2
The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments.25年后的埃德蒙顿症状评估系统:过去、现在及未来发展
J Pain Symptom Manage. 2017 Mar;53(3):630-643. doi: 10.1016/j.jpainsymman.2016.10.370. Epub 2016 Dec 29.
3
How far along the disease trajectory? An examination of the time-related patient characteristics in the palliative oncology literature.疾病进展到何种程度?对姑息肿瘤学文献中与时间相关的患者特征进行的考察。
Support Care Cancer. 2016 Sep;24(9):3997-4004. doi: 10.1007/s00520-016-3225-z. Epub 2016 Apr 29.
4
Personalized symptom goals and response in patients with advanced cancer.晚期癌症患者的个性化症状目标与反应
Cancer. 2016 Jun 1;122(11):1774-81. doi: 10.1002/cncr.29970. Epub 2016 Mar 11.
5
Minimal Clinically Important Difference in the Physical, Emotional, and Total Symptom Distress Scores of the Edmonton Symptom Assessment System.埃德蒙顿症状评估系统身体、情感及总症状困扰评分的最小临床重要差异
J Pain Symptom Manage. 2016 Feb;51(2):262-9. doi: 10.1016/j.jpainsymman.2015.10.004. Epub 2015 Oct 19.
6
The Brazilian Version of the Edmonton Symptom Assessment System (ESAS) Is a Feasible, Valid and Reliable Instrument for the Measurement of Symptoms in Advanced Cancer Patients.巴西版埃德蒙顿症状评估系统(ESAS)是一种用于测量晚期癌症患者症状的可行、有效且可靠的工具。
PLoS One. 2015 Jul 8;10(7):e0132073. doi: 10.1371/journal.pone.0132073. eCollection 2015.
7
Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter study.癌症患者埃德蒙顿症状评估量表的最小临床重要差异:一项前瞻性多中心研究。
Cancer. 2015 Sep 1;121(17):3027-35. doi: 10.1002/cncr.29437. Epub 2015 Jun 8.
8
Modified Edmonton Symptom Assessment System including constipation and sleep: validation in outpatients with cancer.改良版埃德蒙顿症状评估系统(包括便秘和睡眠):在癌症门诊患者中的验证
J Pain Symptom Manage. 2015 May;49(5):945-52. doi: 10.1016/j.jpainsymman.2014.10.013. Epub 2014 Dec 15.
9
Why is high-quality research on palliative care so hard to do? Barriers to improved research from a survey of palliative care researchers.为什么高质量的姑息治疗研究如此难以开展?基于姑息治疗研究人员调查的研究改进障碍。
J Palliat Med. 2014 Jul;17(7):782-7. doi: 10.1089/jpm.2013.0589. Epub 2014 Jun 2.
10
Clinical signs of impending death in cancer patients.癌症患者濒死的临床体征。
Oncologist. 2014 Jun;19(6):681-7. doi: 10.1634/theoncologist.2013-0457. Epub 2014 Apr 23.